Breast
Progress in genetic testing, such as BRCA1 and BRCA2 mutations, has transformed preventative strategies. Targeted therapies like HER2 inhibitors and advancements in hormone therapy have significantly improved survival rates.
Eating eggs may increase cancer risks
A recent study from Harvard University has found a potential connection between egg consumption and the risk of developing certain types of cancer, including breast, ovarian, and fatal prostate cancer.
Certain genetic alterations may contribute to primary resistance of certain cancers to KRAS G12C inhibitors
The KRAS G12C mutation is found in approximately 3% of all colorectal cancer cases and 1% to 2% of pancreatic adenocarcinoma cases, according to Hao Xie, MD, PhD, a medical oncologist at Mayo Clinic Comprehensive Cancer Center.
Common malaria drug repurposed to fight cancer
Can a drug that’s used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have secured a patent for the anti-malarial drug pyronaridine to do just that. Pyronaridine has been used to treat the mosquito-borne infectious disease for over 30 years.
New test may predict kidney cancer recurrence
Scientists at the University of Michigan have discovered a way to predict which kidney cancer patients are more likely to have their cancer come back after treatment. Their research could help doctors decide who needs extra treatment and who doesnÕt, making care more personalized instead of using a Òone-size-fits-allÓ approach.
Your Guide To Proactive Colorectal Health And Cancer Prevention
March is National Colorectal Cancer Awareness Month. Make this the month you put embarrassment aside and talk to your physician about this very important part of your overall health. In this article, weÕll arm you with information to help you start the conversation.
Dwyane Wade Is ‘Cancer-Free,’ Wife Gabrielle Union Reveals After Her Husband’s ‘Challenging’ Health Battle
Dwyane Wade miraculously made it through his health battle in private before sharing his story with the world.
Allegheny Health Network using new robotic tool to diagnose lung cancer
As technology advances in the fight against cancer, Allegheny Health Network is using a new robotic tool to diagnose lung cancer.
Telix kidney cancer imaging agent granted FDA priority review
Telix today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for its breakthrough investigational kidney cancer PET[1] imaging agent TLX250-CDx (Zircaix¨[2], 89Zr-DFO-girentuximab), granted a Priority Review and provided a PDUFA[3] date of 27 August 2025, paving the way for a U.S. commercial launch in 2025.
Therapy combo show promise for bladder cancer treatment
A new study suggests that a combination of radiation therapy and immune checkpoint inhibitors (ICIs) may offer a less invasive alternative to bladder removal for patients with muscle-invasive bladder cancer (MIBC).
PAC-MANN diagnoses early-stage pancreatic cancer with 85% accuracy
Scientists at Oregon Health and Science University (OHSU) have developed a new blood test for pancreatic cancer, one of the most deadly forms of the disease. Tests showed up to 85% accuracy in detection, even in early stages.
Self-assembling nanoplatform can boost cancer photoimmunotherapy effectiveness
Photoimmunotherapy is an innovative cancer treatment that combines phototherapy with immunotherapy to selectively target and destroy cancer cells.
CAR T-cells enable record-breaking 18-year nerve cancer remission
CAR T-cells enable record-breaking 18-year nerve cancer remission
